Although further study will be needed to explore the regulatory role and molecular mechanism of NDRG2 in modulation of LDHA expression and aerobic glycolysis of HCC cells, our present findings support the notion that NDRG2, combined with LDHA, might be valuable markers to evaluate the prognosis of HCC patients. The gene discussed is NDRG2; the disease is hepatocellular carcinoma.